scholarly journals Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein–Barr Virus Reactivation

2019 ◽  
Vol Volume 12 ◽  
pp. 3893-3902 ◽  
Author(s):  
Krzysztof Czyzewski ◽  
Magdalena Dziedzic ◽  
Malgorzata Salamonowicz ◽  
Jowita Fraczkiewicz ◽  
Olga Zajac-Spychala ◽  
...  
Keyword(s):  
Risk Factors ◽  
Children And Adolescents ◽  
Epstein Barr Virus ◽  
Hematopoietic Cell Transplantation ◽  
Viral Infections ◽  
Virus Reactivation ◽  
Barr Virus ◽  
Factors Analysis ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation

scholarly journals Risk factors for Epstein–Barr virus reactivation after renal transplantation: Results of a large, multi‐centre study

2021 ◽  
Vol 34 (9) ◽  
pp. 1680-1688
Author(s):  
Arturo Blazquez‐Navarro ◽  
Chantip Dang‐Heine ◽  
Patrizia Wehler ◽  
Toralf Roch ◽  
Chris Bauer ◽  
...  
Keyword(s):  
Risk Factors ◽  
Renal Transplantation ◽  
Epstein Barr Virus ◽  
Virus Reactivation ◽  
Multi Centre Study ◽  
Centre Study ◽  
Barr Virus ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation

scholarly journals Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report

2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Michele Colaci ◽  
Marco Sebastiani ◽  
Gilda Sandri ◽  
Marisa Meacci ◽  
Clodoveo Ferri
Keyword(s):  
Rheumatoid Arthritis ◽  
Epstein Barr Virus ◽  
Viral Infections ◽  
Therapeutic Strategies ◽  
Tnf Alpha ◽  
Virus Reactivation ◽  
Alpha Blockers ◽  
Barr Virus ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation

TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.

Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab

2014 ◽  
Vol 59 (4) ◽  
pp. 255-258 ◽  
Author(s):  
Harinder Gill ◽  
Yu-Yan Hwang ◽  
Thomas S.Y. Chan ◽  
Annie W.K. Pang ◽  
Anskar Y.H. Leung ◽  
...  
Keyword(s):  
Epstein Barr Virus ◽  
Virus Reactivation ◽  
Barr Virus ◽  
Epstein Barr ◽  
Epstein Barr Virus Reactivation
Sign in / Sign up

Export Citation Format

Share Document